The safety of oseltamivir in pregnancy: An updated review of post-marketing data

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 10, 2014, Pages 1035-1042

  Wollenhaupt, Martina ^a   Chandrasekaran, Abhijeeth ^b   Tomianovic, Danitza ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Clinical Science RxMD   (India)

Author keywords

Influenza; Oseltamivir; Pharmacoepidemiology; Pregnancy; Safety

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FETUS OUTCOME; HIGH RISK PREGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; POSTMARKETING SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; SIDE EFFECT; SPONTANEOUS ABORTION; THERAPEUTIC ABORTION; COMPLICATION; DRUG EFFECTS; EMBRYO DEVELOPMENT; FACTUAL DATABASE; FETUS DEVELOPMENT; INFLUENZA, HUMAN; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANTIVIRAL AGENTS; DATABASES, FACTUAL; EMBRYONIC DEVELOPMENT; FEMALE; FETAL DEVELOPMENT; HUMANS; INFLUENZA, HUMAN; OSELTAMIVIR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 84907863702     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3673     Document Type: Article

References (50)

1. Mereckiene J, Cotter S, Weber JT, et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 2012; 17: pii: 20064.
2. WHO. WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses, 2010. Available at: http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf [1 August 2013].
3. CDC. Seasonal influenza (flu). Influenza Antiviral Medications: Summary for Clinicians, 2012. Available at: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm [1 August 2013].
4. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 infection: a meta-analysis of individual participant data. Lancet Respir Med 2014. doi:10.1016/S2213-2600(14)70041-4.
5. Donner B, Niranjan V, Hoffmann G. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Drug Saf 2010; 33: 631-642. doi:10.2165/11536370-000000000-00000.
6. Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics. McGraw-Hill: New York, NY, 2005; 231-251.
7. Ventura SJ, Curtin SC, Abma JC, et al. Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008. Natl Vital Stat Rep 2012; 60: 1-21.
8. Blohm F, Fridén B, Milsom I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BJOG 2008; 115: 176-182.
9. Swedish Medical Birth Register. Available at: http://www.socialstyrelsen.se/statistics [1 August 2013].
10. MacDorman MF, Kirmeyer SE, Wilson EC. Fetal and perinatal mortality, United States, 2006. Natl Vital Stat Rep 2012; 60: 1-22.
11. Ahman E, Zupan J. Neonatal and perinatal mortality. Country, regional and global estimates 2004. World Health Organization: Geneva, 2007. Available at: http://apps.who.int/iris/bitstream/10665/43800/1/9789241596145_eng.pdf [1 August 2013].
12. Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2010. Natl Vital Stat Rep 2012; 61: 1-100.
13. ONS. Preterm births, data: reference tables, July 2007. Available at: www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-50818 [1 August 2013].
14. EUROCAT. Prevalence tables2007-2011. Available at: http://www.eurocat-network.eu/accessprevalencedata/prevalencetables [1 August 2013].
15. CDC. Update on overall prevalence of major birth defects - Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008; 57: 1-5.
16. Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. Natl Vital Stat Rep 2011; 60: 1-70.
17. Kliegman RM, Stanton BMD, St. Geme J, Schor N, Behrman RE. Nelson Textbook of Pediatrics. Saunders: Philadelphia, PA, 2001; 756-765.
18. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis 2008; 14: 95-100. doi:10.3201/eid1401.070667.
19. Acs N, Bánhidy F, Puhó E, et al. Pregnancy complications and delivery outcomes of pregnant women with influenza. J Matern Fetal Neonatal Med 2006; 19: 135-140.
20. Cox S, Posner SF, McPheeters M, et al. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol 2006; 107: 1315-1322.
21. Hardy JMB, Azarowicz EN, Mannini A, et al. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health Nations Health 1961; 51: 1182-1188.
22. Irving WL, James DK, Stephenson T, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000; 107: 1282-1289.
23. Griffiths PD, Ronalds CJ, Heath RB. A prospective study of influenza infections during pregnancy. J Epidemiol Community Health 1980; 34: 124-128.
24. Lynberg MC, Khoury MJ, Lu X, et al. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 1994; 140: 244-255.
25. Saxen L, Holmberg PC, Kurppa K, et al. Influenza epidemics and anencephaly. Am J Public Health 1990; 80: 473-475.
26. Acs N, Bánhidy F, Puhó E, et al. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 2005; 73: 989-996.
27. Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
28. Iida M, Sakai M. A statistical study of fistula auris congenita in Japan. Tokai J Exp Clin Med 1997; 22: 133-136.
29. Grewe S. Therapy for congenital dacryostenosis [German]. Klin Monbl Augenhelkd 2010; 227: 564-567. doi:10.1055/s-0029-1245485.
30. Lim ML, Chong CY, Tee WSN, et al. Influenza A/H1N1 (2009) infection in pregnancy - an Asian perspective. BJOG 2010; 117: 551-556. doi:10.1111/j.1471-0528.2010.02522.x.
31. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374: 451-458. doi:10.1016/S0140-6736(09)61304-0.
32. Creanga AA, Johnson TF, Graitcer SB, et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010; 115: 717-726. doi:10.1097/AOG.0b013e3181d57947.
33. CDC. Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1) - United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep 2011; 60: 1193-1196.
34. Ellington SR, Hartman LK, Acosta M, et al. Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California. Am J Obstet Gynecol 2011; 204(Suppl. 1): S21-S30. doi:10.1016/j.ajog.2011.02.038.
35. Yates L, Pierce M, Stephens S, et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess 2010; 14: 109-182. doi:10.3310/hta14340-02.
36. Pierce M, Kurinczuk JJ, Spark P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011; 342: d3214. doi:10.1136/bmj.d3214.
37. Dede FS, Celen S, Bilgin S, et al. Maternal deaths associated with H1N1 influenza virus infection in Turkey: a whole-of-population report. BJOG 2011; 118: 1216-1222. doi:10.1111/j.1471-0528.2011.03002.x.
38. Figueiró-Filho EA, Oliveira ML, Pompilio MA, et al. Obstetric, clinical, and perinatal implications of H1N1 viral infection during pregnancy. Int J Gynaecol Obstet 2012; 116: 214-218. doi:10.1016/j.ijgo.2011.10.026.
39. Kanmaz HG, Oguz SS, Erdeve O, et al. Dealing with pandemic influenza A during postpartum and early neonatal period in a busy family-centered neonatal intensive care unit. J Matern Fetal Neonatal Med 2011; 24: 804-807. doi:10.3109/14767058.2010.531308.
40. Zhang PJ, Li XL, Cao B, et al. Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China. BMC Infect Dis 2012; 12: 29. doi:10.1186/1471-2334-12-29.
41. Malinowski AK, McGeer A, Robertson J, et al. H1N1 in pregnancy: a tertiary care centre experience. J Obstet Gynaecol Can 2011; 33: 698-704.
42. Varner MW, Rice MM, Anderson B, et al. Influenza-like illness in hospitalized pregnant and postpartum women during the 2009-2010 H1N1 pandemic. Obstet Gynecol 2011; 118: 593-600. doi:10.1097/AOG.0b013e318229e484.
43. Svensson T, Granath F, Stephansson O, et al. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Pharmacoepidemiol Drug Saf 2011; 20: 1030-1034. doi:10.1002/pds.2194.
44. Hayashi M, Yamane R, Tanaka M, et al. Pregnancy outcome after maternal exposure to oseltamivir phosphate during the first trimester: a case series survey. J Jpn Soc Hosp Pharm 2009; 45: 547-550.
45. Greer LG, Sheffield JS, Rogers VL, et al. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 2010; 115: 711-716. doi:10.1097/AOG.0b013e3181d44752.
46. Lim ML, Lim WY, Tee NW, et al. Obstetric outcomes of influenza A H1N1 (2009) infection in pregnancy - experience of a Singapore tertiary hospital. Ann Acad Med Singapore 2010; 39: 295-298.
47. Netteburg D, Bsat F, Healy A, et al. The use of high-frequency oscillatory ventilation in a patient with H1N1 pneumonia. J Matern Fetal Neonatal Med 2011; 24: 264-266. doi:10.3109/14767058.2010.484470.
48. Meijer WJ, Bruinse HW, van den Broek MP, et al. Oseltamivir and its active metabolite cross the placenta at significant levels. Clin Infect Dis 2012; 54: 1676. doi:10.1093/cid/cis265.
49. Beigi RH, Han K, Venkataramanan R, et al. Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol 2011; 204(Suppl. 1): S84-S88. doi:10.1016/j.ajog.2011.03.002.
50. Bar-Oz B, Moretti ME, Mareels G, et al. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999; 354: 1700-1701.